| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5698449 | Clinical Oncology | 2016 | 7 Pages |
Abstract
Using 18F-FDG-4DPET/4DCT, it is feasible to dose escalate both primary and nodal disease in most patients. Choosing week 0 images to plan a course with an integrated boost to PET-avid disease allows for more patients to be successfully dose escalated with the highest boost dose.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
M.L. Yap, A. Sun, J. Higgins, K. Clarke, A. Marshall, N. Becker, L.W. Le, D.C. Vines, A. Bezjak, J.-P. Bissonnette,